{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:54:02Z","timestamp":1791536042781,"version":"4.3.4"},"reference-count":40,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Kidney cancer represents a substantial and heterogeneous health burden across Europe. Using contemporary GLOBOCAN 2024 estimates, we provide a granular assessment of kidney cancer epidemiology across European countries, integrating geographical, sex- and age-specific, temporal, and socioeconomic patterns with evidence on risk factors and the relationship between kidney cancer and kidney disease. In 2024, an estimated 116,582 new cases and 42,516 deaths occurred across the countries included. Although the absolute burden was greatest in Western Europe, median country-specific age-standardized incidence rates were highest in Northern and Eastern Europe, illustrating marked geographical heterogeneity. Kidney cancer occurred almost twice as frequently in males as in females, and most cases and deaths occurred after 60 years of age. Incidence has increased or remained stable in most European populations, while mortality has declined or stabilized in many countries. Demographic projections indicate that, if 2024 rates remain unchanged, incident cases may increase by 18.7% and deaths by 38.9% by 2050. Higher incidence in more affluent European countries does not consistently parallel the geographical distribution of established risk factors and may also reflect differences in diagnostic intensity, cancer registration, and healthcare access. Kidney cancer and chronic kidney disease share major metabolic and behavioural risk factors, while epidemiological and experimental evidence supports a potentially bidirectional relationship between kidney injury and renal carcinogenesis. These interactions highlight an important role for nephrology in kidney cancer prevention, preservation of kidney function, and multidisciplinary cancer care.<\/jats:p>","DOI":"10.1093\/ndt\/gfag216","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:22:22Z","timestamp":1790266942000},"source":"Crossref","is-referenced-by-count":0,"title":["European epidemiology of kidney cancer"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4654-9002","authenticated-orcid":false,"given":"Neriman S\u0131la","family":"Ko\u00e7","sequence":"first","affiliation":[{"name":"Department of Nephrology, Ankara Etlik City Hospital , Ankara ,","place":["T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"2026100904413456300_bib1","first-page":"e70090","article-title":"Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries","volume":"76","author":"Sung","year":"2026","journal-title":"CA Cancer J Clin"},{"key":"2026100904413456300_bib2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ijc.70349","article-title":"Global patterns and trends in kidney cancer incidence and mortality","volume":"159","author":"Barchuk","year":"2026","journal-title":"Int J Cancer"},{"key":"2026100904413456300_bib3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.eururo.2025.06.005","article-title":"Epidemiology of renal cancer: incidence, mortality, survival, genetic predisposition, and risk factors","volume":"88","author":"Larcher","year":"2025","journal-title":"Eur Urol"},{"key":"2026100904413456300_bib4","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/ndt\/gfae036","article-title":"Global epidemiology of kidney cancer","volume":"39","author":"Cirillo","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2026100904413456300_bib5","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1093\/ndt\/gfad249","article-title":"Chronic kidney disease and risk of kidney or urothelial malignancy: systematic review and meta-analysis","volume":"39","author":"Brooks","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2026100904413456300_bib6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.kint.2021.03.011","article-title":"From kidney injury to kidney cancer","volume":"100","author":"Peired","year":"2021","journal-title":"Kidney Int"},{"key":"2026100904413456300_bib7","article-title":"Global cancer observatory: cancer today [Internet]","year":"14  2026"},{"key":"2026100904413456300_bib8","article-title":"United nations statistics division standard country or area codes for statistical use: M49 geographical regions [Internet]","year":"14  2026"},{"key":"2026100904413456300_bib9","article-title":"Global cancer observatory: cancer tomorrow [Internet]","year":"14  2026"},{"key":"2026100904413456300_bib10","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1002\/ijc.33147","article-title":"Incidence of childhood renal tumours: an international population-based study","volume":"147","author":"Nakata","year":"2020","journal-title":"Int J Cancer"},{"key":"2026100904413456300_bib11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11912-025-01644-8","article-title":"Paediatric renal tumors: a state-of-the-art review","volume":"27","author":"Salzillo","year":"2025","journal-title":"Curr Oncol Rep"},{"key":"2026100904413456300_bib12","first-page":"575","article-title":"Non-wilms renal tumours in children: the republic of Ireland experience","volume":"13","author":"Hughes","year":"2026","journal-title":"Children (Basel)"},{"key":"2026100904413456300_bib13","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1080\/0284186X.2020.1822544","article-title":"Trends in cancer survival in the nordic countries 1990-2016: the nordcan survival studies","volume":"59","author":"Lundberg","year":"2020","journal-title":"Acta Oncol"},{"key":"2026100904413456300_bib14","article-title":"Urological cancers in Ireland 1994\u20132023. 2026","author":"National Cancer Registry Ireland","year":"18  2026"},{"key":"2026100904413456300_bib15","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/j.ejca.2015.07.028","article-title":"Urinary tract cancer survival in europe 1999-2007: results of the population-based study eurocare-5","volume":"51","author":"Marcos-Gragera","year":"2015","journal-title":"Eur J Cancer"},{"key":"2026100904413456300_bib16","article-title":"Cancer survival in england, cancers diagnosed 2018 to 2022, followed up to 2023","author":"England","year":"2026"},{"key":"2026100904413456300_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1470-2045(13)70546-1","article-title":"Cancer survival in Europe 1999-2007 by country and age: results of eurocare\u20145-a population-based study","volume":"15","author":"De\u00a0Angelis","year":"2014","journal-title":"Lancet Oncol"},{"key":"2026100904413456300_bib18","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41585-023-00781-8","article-title":"Effect of smoking, hypertension and lifestyle factors on kidney cancer\u2014perspectives for prevention and screening programmes","volume":"20","author":"Campi","year":"2023","journal-title":"Nat Rev Urol"},{"key":"2026100904413456300_bib19","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.eururo.2015.06.042","article-title":"The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks","volume":"70","author":"Cumberbatch","year":"2016","journal-title":"Eur Urol"},{"key":"2026100904413456300_bib20","doi-asserted-by":"publisher","first-page":"e12860","DOI":"10.1097\/MD.0000000000012860","article-title":"The association between bmi and kidney cancer risk: an updated dose-response meta-analysis in accordance with prisma guideline","volume":"97","author":"Liu","year":"2018","journal-title":"Medicine"},{"key":"2026100904413456300_bib21","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1097\/HJH.0000000000001286","article-title":"Blood pressure and kidney cancer risk: meta-analysis of prospective studies","volume":"35","author":"Hidayat","year":"2017","journal-title":"J Hypertens"},{"key":"2026100904413456300_bib22","doi-asserted-by":"publisher","first-page":"832","DOI":"10.2174\/0118715303256408230925060414","article-title":"Meta-analysis of the relationship between type 2 diabetes mellitus and renal cancer risk","volume":"24","author":"Wang","year":"2024","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"2026100904413456300_bib23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12944-024-02138-5","article-title":"Association between metabolic syndrome and kidney cancer risk: a prospective cohort study","volume":"23","author":"Wang","year":"2024","journal-title":"Lipids Health Dis"},{"key":"2026100904413456300_bib24","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1038\/s41467-024-48857-2","article-title":"Ambient air pollution and urological cancer risk: a systematic review and meta-analysis of epidemiological evidence","volume":"15","author":"Li","year":"2024","journal-title":"Nat Commun"},{"key":"2026100904413456300_bib25","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults","volume":"403","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2024","journal-title":"Lancet"},{"key":"2026100904413456300_bib26","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2021","journal-title":"Lancet"},{"key":"2026100904413456300_bib27","doi-asserted-by":"crossref","DOI":"10.1787\/b3704e14-en","article-title":"Health at a glance: Europe 2024: state of health in the eu cycle","author":"OECD","year":"2024"},{"key":"2026100904413456300_bib28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.euros.2025.10.009","article-title":"Genetic testing and counselling for hereditary renal carcinoma: what do clinicians need to know?","volume":"82","author":"Re","year":"2025","journal-title":"Eur Urol Open Sci"},{"key":"2026100904413456300_bib29","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/ndt\/gfac011","article-title":"The \u2018other\u2019 big complication: how chronic kidney disease impacts on cancer risks and outcomes","volume":"38","author":"Lees","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2026100904413456300_bib30","doi-asserted-by":"publisher","first-page":"sfaf084","DOI":"10.1093\/ckj\/sfaf084","article-title":"Incidence of cancer in people with ckd not requiring kidney replacement therapy: a systematic review and meta-analysis","volume":"18","author":"Elyan","year":"2025","journal-title":"Clin Kidney J"},{"key":"2026100904413456300_bib31","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/s41416-025-03140-z","article-title":"Chronic kidney disease and incident cancer risk: an individual participant data meta-analysis","volume":"133","author":"Mok","year":"2025","journal-title":"Br J Cancer"},{"key":"2026100904413456300_bib32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/01.ASN.0000039608.81046.81","article-title":"Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the united states, Europe, and Australia and new Zealand","volume":"14","author":"Stewart","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2026100904413456300_bib33","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.3346\/jkms.2019.34.e176","article-title":"The incidences and characteristics of various cancers in patients on dialysis: a Korean nationwide study","volume":"34","author":"Kwon","year":"2019","journal-title":"J Korean Med Sci"},{"key":"2026100904413456300_bib34","doi-asserted-by":"publisher","first-page":"102050","DOI":"10.1016\/j.clgc.2024.02.001","article-title":"Acquired cystic disease-associated renal cell carcinoma: a systematic review and meta-analysis","volume":"22","author":"Duong","year":"2024","journal-title":"Clin Genitourin Cancer"},{"key":"2026100904413456300_bib35","doi-asserted-by":"publisher","first-page":"eaaw6003","DOI":"10.1126\/scitranslmed.aaw6003","article-title":"Acute kidney injury promotes development of papillary renal cell adenoma and carcinoma from renal progenitor cells","volume":"12","author":"Peired","year":"2020","journal-title":"Sci Transl Med"},{"key":"2026100904413456300_bib36","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1158\/0008-5472.CAN-20-2930","article-title":"Acute kidney injury instigates malignant renal cell carcinoma via cxcr2 in mice with inactivated trp53 and pten in proximal tubular kidney epithelial cells","volume":"81","author":"Zhou","year":"2021","journal-title":"Cancer Res"},{"key":"2026100904413456300_bib37","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.urolonc.2022.11.024","article-title":"Renal functional and cardiovascular outcomes of partial nephrectomy versus radical nephrectomy for renal tumors: a systematic review and meta-analysis","volume":"41","author":"Ochoa-Arvizo","year":"2023","journal-title":"Urol Oncol"},{"key":"2026100904413456300_bib38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3233\/KCA-230018","article-title":"Nephrotoxicity associated with contemporary renal cell carcinoma regimens: a systematic review and meta-analysis","volume":"7","author":"Dukkipati","year":"2023","journal-title":"Kidney Cancer"},{"key":"2026100904413456300_bib39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.semnephrol.2019.12.006","article-title":"Renal toxicity of systemic therapy for renal cell carcinoma","volume":"40","author":"Jaimes","year":"2020","journal-title":"Semin Nephrol"},{"key":"2026100904413456300_bib40","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00280-021-04260-y","article-title":"Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney function","volume":"87","author":"Mielczarek","year":"2021","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfag216\/71382475\/gfag216.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfag216\/71382475\/gfag216.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:41:38Z","timestamp":1791535298000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article\/doi\/10.1093\/ndt\/gfag216\/8833853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":40,"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfag216","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"article-number":"gfag216"}}